Carterra Launches Sensitive Platform: Ultra™ Advan...
Category : Approval/Launch 6 September 2024Overview Carterra has unveiled its latest platform, Carterra Ultra™, an addition to its LSA...
Overview Carterra has unveiled its latest platform, Carterra Ultra™, an addition to its LSA...
Despite trial scare, Travere’s Filspari gains full FDA nod in kidney disease showdown with Nov...
Overview UltraDx Bio has announced that its flagship product, the UD-X Fully Automated Single-Mol...
Regenxbio reports positive results from phase I/II/III CAMPSIITE trial of RGX-121 to treat patients...
Overview Merck, known as MSD outside of the United States and Canada, and EyeBio, a wholly-owned...